ArticleFrontiers in medicine2026
Identification and validation of druggable targets for cataract using mendelian randomization: functional insights from multi-omics and an oxidative stress model.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify druggable genes associated with cataract and investigate their functional roles under oxidative stress, thereby providing potential therapeutic targets. Methods: Multi-omics data were integrated, and expression quantitative trait loci (eQTL) and protein quantitative trait loci (pQTL) analyses, along with Mendelian randomization (MR), were performed to assess the causal relationships between gene/protein expression and cataract risk. Phenome-wide association studies (PheWAS), the creation of protein-protein interaction networks, drug prediction, and molecular docking were further performed to evaluate their functional relevance and potential for drug development. In addition, an oxidative stress model was established by treating SRA01/04 lens epithelial cells with H Results: Among 2,532 drug-associated genes, 35 eQTL genes and 31 pQTL genes were identified, with DKK3, GSTM1, and KIR2DS4 showing significant associations in both analyses. PheWAS revealed no major adverse effects, and drug prediction and molecular docking suggested GSTM1 as the most promising target. Conclusion: This study identified and validated DKK3 and GSTM1 as key genes in cataract pathogenesis. By integrating genetic analyses with functional experiments, our findings provide new insights into the molecular mechanisms of cataract and establish a theoretical basis for drug development and repurposing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.